Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Centella AI streamlines drug discovery using AI-powered platforms, reducing R&D time and cost with real-world scientific validation ...

Understanding protein motion is essential to understanding biology and advancing drug discovery,” said Nadella, in a post on ...

Microsoft's BioEmu, an AI-driven model, decodes protein motion to enhance drug discovery, offering rapid insights into protein structures and functions.

The start-up, which aims to raise tens of millions of US dollars in an angel funding round, hopes to compete globally, ...

Microsoft’s new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

Hiding in Plain Sight Quantum computing has surged from theoretical curiosity to a transformative frontier, promising to ...

Microsoft's CEO, Satya Nadella, has introduced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding protein motion.

TandemAI, a company transforming drug discovery with state-of-the-art AI and physics-based technologies integrated with full wet lab capabilities, and Perpetual Medicines, which is advancing a ...

Certara's financials are strong, with stable cash flow, a healthy balance sheet. Read here to know why we recommend a buy ...

A teenager who lost her mother, aunt and uncle to a genetic condition has become the first person in Europe to receive a ...

Reactions that alter organic scaffolds by a single atom are already proving useful, but time will tell if they’ll ...